Metildigoxin

This classification denotes an anti-arrhythmia agent, cardiotonic agent, and enzyme inhibitor with the molecular formula C42H66O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I7GG1YUC5V, chemically known as digoxin, 4-o-methyl- but more generally known as metildigoxin, which bears US NIH Compound Identifier 35418. European Medicines Agency schedules Metildigoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08887MIG. World Health Organization schedules metildigoxin in its Anatomical Therapeutic Chemical (ATC) Classification. METILDIGOXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule metildigoxin under HS 29389010 and SITC 54161. As of Q4 2014, METILDIGOXIN remains US FDA's Preferred Term for this commodity. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(OC)C(O)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CC(O)C1(C(CC2)C1=CC(=O)OC1)C.